Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Drugs/Products That May Increase Cancer Risk
  5. Drugs

Drugs

  • Anemia (51)
  • Blood Products (5)
  • Breast Cancer (56)
  • Cancer (19)
  • Cervical Cancer (18)
  • Chemotherapy (5)
  • Chemotherapy-Induced Adverse Effects (35)
  • Colon Cancer (17)
  • Drugs/Products That May Increase Cancer Risk (113)
    • Drugs (85)
    • Natural Medicines/Supplements (11)
    • Other (17)
  • Gastrointestinal Cancers (32)
  • Hemophilia (4)
  • Hemorrhage (7)
  • Leukemia (1)
  • Lung Cancer (93)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (5)
  • Prostate Cancer (29)
  • Renal Cancer (1)
  • Resources (75)
  • Sickle Cell Disease (3)
  • Skin Cancer (22)
61 - 75 of 85 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Hormonal Effects of Opioids February 2011
Article: whether postmenopausal estrogen plus progestin therapy increases breast cancer risk December 2010
Commentary: Postmenopausal Hormone Therapy and Cancer Risk December 2010
Article: new concerns that bisphosphonates might increase the risk of esophageal cancer and femur fractures October 2010
Article: possible link between Actos (pioglitazone) and bladder cancer October 2010
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Other: FDA Podcast: Bisphosphonates and Risk of Esophageal Cancer (July 2011) October 2010
Commentary: Bisphosphonates: Esophageal Cancer and Other Safety Concerns October 2010
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Article: whether angiotensin receptor blockers increase cancer or cardiovascular risk August 2010
Commentary: Olmesartan (Benicar) and Cardiovascular Risk August 2010
Commentary: Angiotensin Receptor Blockers (ARBs) and Cancer Risk August 2010
Article: if hormone therapy increases cancer risk June 2010
Article: concerns about using Protopic (tacrolimus) and Elidel (pimecrolimus) for eczema in kids May 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved